{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:38Z","timestamp":1791308858905,"version":"4.3.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T00:00:00Z","timestamp":1282780800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0012416","type":"journal-article","created":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T19:36:03Z","timestamp":1282851363000},"page":"e12416","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Characterization of Botulinum Neurotoxin Type A Neutralizing Monoclonal Antibodies and Influence of Their Half-Lives on Therapeutic Activity"],"prefix":"10.1371","volume":"5","author":[{"given":"Christelle","family":"Mazuet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel R.","family":"Popoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Cr\u00e9minon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Volland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,8,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00066982-200106040-00013","article-title":"Biological agents: weapons of warfare and bioterrorism.","volume":"6","author":"LA Broussard","year":"2001","journal-title":"Mol Diagn"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.1073\/pnas.2233819100","article-title":"Botulinum toxin type B micromechanosensor.","volume":"100","author":"W Liu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","first-page":"473","article-title":"Efficacy of prophylactic and therapeutic administration of antitoxin for inhalation botulism.","author":"DR Franz","year":"1993"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.8.6.501","article-title":"Production of Monovalent botulinus antitoxic serum types A and B.","volume":"8","author":"MW Wheeler","year":"1923","journal-title":"The Journal of Immunology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.toxicon.2006.05.007","article-title":"Botulinum type A toxin neutralisation by specific IgG and its fragments: A comparison of mouse systemic toxicity and local flaccid paralysis assays.","volume":"48","author":"RGA Jones","year":"2006","journal-title":"Toxicon"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/IAI.69.1.570-574.2001","article-title":"High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A.","volume":"69","author":"DD Pless","year":"2001","journal-title":"Infection and Immunity"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1128\/AEM.67.7.3201-3207.2001","article-title":"Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A.","volume":"67","author":"HC Wu","year":"2001","journal-title":"Applied and Environmental Microbiology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/S0264-410X(02)00157-3","article-title":"Production and immunogenic efficacy of botulinum tetravalent (A, B, E, F) toxoid.","volume":"20","author":"Y Torii","year":"2002","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0002-9343(80)90469-6","article-title":"Hypersensitivity Reactions Associated with Botulinal Antitoxin.","volume":"69","author":"RE Black","year":"1980","journal-title":"American Journal of Medicine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/IAI.65.9.3743-3752.1997","article-title":"Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries.","volume":"65","author":"P Amersdorfer","year":"1997","journal-title":"Infection and Immunity"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.","volume":"99","author":"A Nowakowski","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref12","first-page":"384","article-title":"Immunogenicity and Kinetics of Distribution and Elimination of Sheep Digoxin-Specific Igg and Fab Fragments in the Rabbit and Baboon.","volume":"36","author":"TW Smith","year":"1979","journal-title":"Clinical and Experimental Immunology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1081\/IPH-120024507","article-title":"Anti-immunoglobulin responses to IgG, F(ab&apos;)(2), and fab botulinum antitoxins in mice.","volume":"25","author":"CN Mayers","year":"2003","journal-title":"Immunopharmacology and Immunotoxicology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(99)00458-5","article-title":"Modulating pharmacokinetics of an anti-interleukin-8 F(ab&apos;)(2) by amine-specific PEGylation with preserved bioactivity.","volume":"198","author":"IL Koumenis","year":"2000","journal-title":"International Journal of Pharmaceutics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/cyto.2001.0936","article-title":"Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylation.","volume":"16","author":"SR Leong","year":"2001","journal-title":"Cytokine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/11717","article-title":"Therapeutic antibody fragments with prolonged in vivo half-lives.","volume":"17","author":"AP Chapman","year":"1999","journal-title":"Nature Biotechnology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0169-409X(02)00026-1","article-title":"PEGylated antibodies and antibody fragments for improved therapy: a review.","volume":"54","author":"AP Chapman","year":"2002","journal-title":"Advanced Drug Delivery Reviews"},{"key":"ref18","first-page":"143","article-title":"Growth of clostridia and preparation of their neurotoxins.","author":"CC Shone","year":"1995"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.febslet.2004.06.094","article-title":"Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies.","volume":"572","author":"M Tavallaie","year":"2004","journal-title":"Febs Letters"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jim.2007.11.006","article-title":"A sensitive sandwich enzyme immunoassay for free or complexed Clostridium botulinum neurotoxin type A.","volume":"330","author":"H Volland","year":"2008","journal-title":"Journal of Immunological Methods"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0022-1759(83)90415-5","article-title":"Preparation of F(Ab&apos;)2 Fragments from Mouse Igg of Various Subclasses.","volume":"56","author":"E Lamoyi","year":"1983","journal-title":"Journal of Immunological Methods"},{"key":"ref22","first-page":"93","article-title":"Immunogenicity of neurotoxins of <italic>Clostridium Botulinum<\/italic> in therapy with botulinum toxin.","author":"CL Hatheway","year":"1994"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/JB.01180-06","article-title":"Genetic diversity among botulinum neurotoxin-producing clostridial strains.","volume":"189","author":"KK Hill","year":"2007","journal-title":"Journal of Bacteriology"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-10-115","article-title":"Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum.","volume":"10","author":"AT Carter","year":"2009","journal-title":"Bmc Genomics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1128\/JCM.00799-09","article-title":"Novel Clostridium botulinum Toxin Gene Arrangement with Subtype A5 and Partial Subtype B3 Botulinum Neurotoxin Genes.","volume":"47","author":"N Dover","year":"2009","journal-title":"Journal of Clinical Microbiology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1128\/IAI.73.9.5450-5457.2005","article-title":"Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralizaiion.","volume":"73","author":"TJ Smith","year":"2005","journal-title":"Infection and Immunity"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0041-0101(98)00146-9","article-title":"Development of recombinant vaccines for botulinum neurotoxin.","volume":"36","author":"LA Smith","year":"1998","journal-title":"Toxicon"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/IAI.63.7.2738-2742.1995","article-title":"Protective Vaccination with A Recombinant Fragment of Clostridium-Botulinum Neurotoxin Serotype A Expressed from A Synthetic Gene in Escherichia-Coli.","volume":"63","author":"MA Clayton","year":"1995","journal-title":"Infection and Immunity"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0041-0101(00)00189-6","article-title":"Anomalous enhancement of botulinum toxin type A neurotoxicity in the presence of antitoxin.","volume":"39","author":"RE Sheridan","year":"2001","journal-title":"Toxicon"},{"key":"ref30","first-page":"477","article-title":"Clinical trial of human botulism immune globulin.","author":"SS Arnon","year":"1993"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jmb.2006.07.040","article-title":"A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4.","volume":"362","author":"JW Arndt","year":"2006","journal-title":"Journal of Molecular Biology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1016\/S0021-9258(18)68146-3","article-title":"Relationship of Effective Molecular-Size to Systemic Clearance in Rats of Recombinant Interleukin-2 Chemically Modified with Water-Soluble Polymers.","volume":"263","author":"MJ Knauf","year":"1988","journal-title":"Journal of Biological Chemistry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/jps.20178","article-title":"Antibody pharmacokinetics and pharmacodynamics.","volume":"93","author":"ED Lobo","year":"2004","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0958-1669(02)00352-X","article-title":"Pharmacokinetics and biodistribution of genetically engineered antibodies.","volume":"13","author":"SK Batra","year":"2002","journal-title":"Current Opinion in Biotechnology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0012416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T01:01:28Z","timestamp":1685754088000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0012416"}},"subtitle":[],"editor":[{"given":"Holger","family":"Bruggemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,8,26]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,8,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0012416","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,26]]}}}